3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT

BACKGROUND: The bone marrow (BM) is a main risk organ during Lu-177-PSMA ligand therapy of metastasized castration-resistant prostate cancer (mCRPC) patients. So far, BM dosimetry relies on S values, which are pre-computed for reference anatomies, simplified activity distributions, and a physiologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gosewisch, Astrid, Ilhan, Harun, Tattenberg, Sebastian, Mairani, Andrea, Parodi, Katia, Brosch, Julia, Kaiser, Lena, Gildehaus, Franz Josef, Todica, Andrei, Ziegler, Sibylle, Bartenstein, Peter, Böning, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694348/
https://www.ncbi.nlm.nih.gov/pubmed/31414241
http://dx.doi.org/10.1186/s13550-019-0548-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694348/
https://www.ncbi.nlm.nih.gov/pubmed/31414241
http://dx.doi.org/10.1186/s13550-019-0548-z

Ejemplares similares